InstaMed® Pharmaceuticals Announces Month-Over-Month Hypergrowth, Successful Study, and Expands Its Patented Peptide Delivery Platform Nationwide
Salt Lake City
Archived
•
December 11, 2025
•
SALT LAKE CITY, Dec. 11, 2025 /PRNewswire/ -- InstaMed® Pharmaceuticals, a biotechnology innovator, is pioneering the first patented non-injectable peptide delivery system, InstaRelease®, a breakthrough oral dissolving strip technology.
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



